These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24236962)

  • 1. US patent law and the attorney-client privilege.
    Lu DL; Kowalski TJ; Uthaman SB; Megerditchian SH
    Pharm Pat Anal; 2013 Jan; 2(1):1-3. PubMed ID: 24236962
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of the war over the corporate attorney-client privilege on the business of American health care.
    Duggin SH
    J Contemp Health Law Policy; 2006; 22(2):301-48. PubMed ID: 17117700
    [No Abstract]   [Full Text] [Related]  

  • 3. ATTORNEY-CLIENT PRIVILEGE: attorney-client privilege attaches to materials submitted to hospital attorney. St. Luke Hospitals, Inc. v. Kopowski.
    West JC
    J Healthc Risk Manag; 2005; 25(3):36-7. PubMed ID: 23638510
    [No Abstract]   [Full Text] [Related]  

  • 4. Attorney work product privilege trumps mandated child abuse reporting law: The case of Elijah W. v. Superior Court.
    Lareau CR
    Int J Law Psychiatry; 2015; 42-43():43-8. PubMed ID: 26404507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney.
    Melethil S
    AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inventors and their attorneys must beware of their actions before the US Patent & Trademark Office.
    Warburg R; Nguyen L
    Pharmacogenomics; 2004 Mar; 5(2):143-7. PubMed ID: 15016604
    [No Abstract]   [Full Text] [Related]  

  • 7. HIPAA and the hospital-lawyer relationship. Revisiting retention of outside counsel; is attorney-client privilege in doubt?
    Bednar AL
    Healthc Leadersh Manag Rep; 2003 Jun; 11(6):1-2, 6-8. PubMed ID: 12959060
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug development and patent law.
    Nusbaum NJ
    N Y State J Med; 1992 Mar; 92(3):86-7. PubMed ID: 1557205
    [No Abstract]   [Full Text] [Related]  

  • 9. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D
    Food Drug Law J; 2004; 59(2):339-54. PubMed ID: 15298015
    [No Abstract]   [Full Text] [Related]  

  • 10. The challenge to patent law of pure chemical protein synthesis.
    Fellmeth AX
    Nat Biotechnol; 2005 May; 23(5):547-9. PubMed ID: 15877067
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementing environmental compliance: the role of attorney-client privilege.
    Tabler NG
    J Health Hosp Law; 1996; 29(1):27-9. PubMed ID: 10160170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new patent law may accelerate innovation in ophthalmology.
    Higginbotham EJ; Upadhyay A; Egbuonu-Davis L
    JAMA Ophthalmol; 2014 Feb; 132(2):137-8. PubMed ID: 24310429
    [No Abstract]   [Full Text] [Related]  

  • 13. A general approach for determining when to patent, publish, or protect information as a trade secret.
    Daizadeh I; Miller D; Glowalla A; Leamer M; Nandi R; Numark CI
    Nat Biotechnol; 2002 Oct; 20(10):1053-4. PubMed ID: 12355117
    [No Abstract]   [Full Text] [Related]  

  • 14. The introduction of patent agent privilege in Canada.
    Creber E; Thistle J; Norman J
    Pharm Pat Anal; 2019 Jan; 8(1):1-5. PubMed ID: 30873904
    [No Abstract]   [Full Text] [Related]  

  • 15. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 16. Perspectives in patent law: overview, careers, and controversies.
    Davis C
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():157-62. PubMed ID: 19963706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in U.S. patent law for pharmaceuticals.
    Bruderle TP
    Am J Health Syst Pharm; 1995 Oct; 52(19):2088, 2091. PubMed ID: 8535940
    [No Abstract]   [Full Text] [Related]  

  • 18. US trade rules seek to balance health and patent protection.
    Wadman M; Cherry M
    Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448
    [No Abstract]   [Full Text] [Related]  

  • 19. Use patents, carve-outs, and incentives--a new battle in the drug-patent wars.
    Rai A
    N Engl J Med; 2012 Aug; 367(6):491-3. PubMed ID: 22873529
    [No Abstract]   [Full Text] [Related]  

  • 20. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.